Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction-Reference-Cited by-同舟云学术

Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction

Published:2017-02-14 Issue:4 Volume:101 Page:481-490
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Tromp J¹,Steggink LC²,Van Veldhuisen DJ¹,Gietema JA²,van der Meer P¹

Affiliation:

1. Department of Cardiology; University Medical Centre Groningen, University of Groningen; The Netherlands

2. Department of Medical Oncology University Medical Center Groningen; University of Groningen; Groningen The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.614/fullpdf

Reference75 articles.

1. Chronic health conditions in adult survivors of childhood cancer;Oeffinger;N. Engl. J. Med.,2006

2. Detection of anthracycline-induced cardiotoxicity;Meinardi;Cancer Treat. Rev.,1999

3. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention;Albini;J. Natl. Cancer Inst.,2010

4. Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population;Boerman;Support. Care Cancer,2014

5. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur. Heart J.,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy;Acta Pharmaceutica Sinica B;2024-07

2. Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science;Circulation: Heart Failure;2024-04

3. Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications;Biomedicine & Pharmacotherapy;2023-12

4. Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies;Frontiers in Oncology;2022-05-18

5. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection;Frontiers in Cardiovascular Medicine;2022-04-15